Key result
The presence of in-stent neoatherosclerosis was independently associated with a higher risk of major adverse cardiac events compared to patients without neoatherosclerosis.
Why the study?
Does the presence of in-stent neoatherosclerosis increase the risk of major adverse cardiac events in patients treated with coronary stents?
Observational (n=175)
No
Does the presence of in-stent neoatherosclerosis increase the risk of major adverse cardiac events in patients treated with coronary stents?
Answers are grounded in this paper and cite their sources.
Neoatherosclerosis signals higher MACE risk after stenting; hypothesis-generating and should not yet change practice.
AIMS: Although pathological studies have indicated the development of neoatherosclerosis (NA) after stenting, its risk factors and impact on future clinical events remain unclear. We aimed to clarify the possible risk factors for NA development and to evaluate the impact of NA in a large Japanese observational OCT database of patients with coronary heart disease. METHODS AND RESULTS: One hundred and seventy-five consecutive patients (314 lesions) who underwent OCT examination >1 year after bare metal or drug-eluting stent implantation were enrolled. We assessed the presence of NA by follow-up OCT and compared adverse clinical events between NA+ and NA- patients. Forty-six patients had NA at the follow-up OCT. These patients had higher low-density lipoprotein (LDL) cholesterol and C-reactive protein (CRP) levels at follow-up. In multivariate logistic analysis, LDL cholesterol and CRP levels at follow-up were independently associated with the presence of NA (odds ratio [OR]: 1.022, p=0.008, OR 1.022, p=0.001, respectively). Moreover, patients with NA had a higher incidence of major adverse cardiac events (MACE) at follow-up. Multivariate Cox hazard analysis showed that the presence of NA was an independent risk factor for MACE (hazard ratio: 2.909, p=0.012). CONCLUSIONS: High LDL cholesterol and CRP levels may be risk factors for NA development in patients treated with coronary stents. Moreover, the presence of NA was independently associated with MACE, suggesting the need for careful clinical follow-up of these patients.
No takes yet. Share an insight, caveat, or question.
Kuroda et al. (2016) conducted an observational in Coronary artery disease (n=175). In-stent neoatherosclerosis vs. Absence of neoatherosclerosis was evaluated on Major adverse cardiac events (MACE) (HR 2.909, 95% CI 1.265-6.689, p=0.012). The presence of in-stent neoatherosclerosis was independently associated with a higher risk of major adverse cardiac events compared to patients without neoatherosclerosis.
Synapse has enriched 10 related papers. Consider them for comparative context: